20 results
8-K
EX-10.3
PSTX
Poseida Therapeutics Inc
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
confidential information provided to such Third Party (subject to any limitations for competitively sensitive information in order to comply with antitrust laws
8-K
lowhhzc4jrbg ql6em
7 Sep 22
Other Events
8:01am
8-K
EX-99.1
fq1522
11 Aug 22
Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2022
4:27pm
424B5
9c6d3isi99des8mvpdaf
4 Aug 22
Prospectus supplement for primary offering
4:52pm
8-K
n5qrewx2
3 Aug 22
Results of Operations and Financial Condition
4:29pm
424B5
twhykyhs
3 Aug 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
yt09v
3 Aug 22
Poseida Therapeutics Announces Strategic Global
7:36am
8-K
0o3f8ewx
3 Aug 22
Poseida Therapeutics Announces Strategic Global
7:36am
DRS
EX-2.1
38vw75d9oy69hw1rnb
17 Apr 20
Draft registration statement
12:00am
S-1
EX-2.2
c328 j3f7
4 Jan 19
IPO registration
3:19pm
DRS
EX-2.2
jzb0fs3
1 Nov 18
Draft registration statement
12:00am
- Prev
- 1
- Next